7 Sep 2018 14:18
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. | Details of PDMR/person closely associated with them ('PCA') | |||||
a) | Name | Mrs V A Whyte | ||||
b) | Position/status | SVP & Company Secretary | ||||
c) | Initial notification/ amendment | Initial notification | ||||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | GlaxoSmithKline plc | ||||
b) | LEI | 5493000HZTVUYLO1D793 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | |||||
a) | Description of the financial  instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
      | ||||
b) | Nature of the transaction | Award of Ordinary Shares under the Company's 2009 Share Value Plan | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | n/a (single transaction) Â Â | ||||
e) | Date of the transaction | 2018-09-06 | ||||
f) | Place of the transaction  | n/a | ||||
Â
Glaxosmithkline (GSK)